Search results
Intra-Cellular Therapies (NASDAQ:ITCI) Given New $107.00 Price Target at Canaccord Genuity Group
ETF DAILY NEWS· 3 days agoIntra-Cellular Therapies (NASDAQ:ITCI – Free Report) had its target price increased by Canaccord Genuity Group from $100.00 to $107.00 in a research note
Intra-Cellular Therapies (NASDAQ:ITCI) Rating Reiterated by Cantor Fitzgerald
ETF DAILY NEWS· 1 day agoCantor Fitzgerald’s price objective indicates a potential upside of 66.37% from the stock’s previous close. Several other equities analysts have also weighed in on the company ...
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA TODAY· 2 days agoPatients like Price are struggling to afford a blockbuster class of weight-loss medications called...
Pfizer hemophilia gene therapy arrives in US to uncertain future
BioPharma Dive via Yahoo Finance· 1 day ago“The handwriting is on the wall regarding Roctavian,” Piper Sandler analyst Christopher Raymond...
Investing in Taysha Gene Therapies Inc
Knox Daily· 5 days agoB now holds 16,466,667 shares, worth roughly $37.38 million. Piper Sandler initiated its Taysha Gene Therapies Inc [TSHA] rating to an Overweight in a research note published ...
The best places to go shopping in Amsterdam
The Telegraph via Yahoo News· 3 days agoFrom hidden 18th-century bookshops and hip boutiques showcasing the best of Dutch fashion, to cheese emporiums and toy-meets-liquorice shops, retail ...
Bernie Sanders Is Taking on Ozempic’s ‘Astronomically High’ Price Tag
Gizmodo via Yahoo News· 1 day agoSenator Bernie Sanders (I-VT) is taking aim at one of Big Pharma’s newest cash cows: the latest...
Are Megan Fox, MGK Still Together 2023? She Still With Machine Gun Kelly?
STYLECASTER via Yahoo News· 2 days agoOur mission at STYLECASTER is to bring style to the people, and we only feature products we think...
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Benzinga via Yahoo Finance· 20 hours agoFriday, the FDA approved Pfizer Inc’s (NYSE:PFE) Beqvez (fidanacogene elaparvovec-dzkt) for moderate...
Taysha Gene Therapies Inc (TSHA) Shares Rise Despite Market Challenges – News Heater
NewsHeater· 3 days agoTaysha Gene Therapies Inc (NASDAQ: TSHA) has seen a rise in its stock price by 2.85 in relation to its previous close of 2.46. Is It Worth Investing in Taysha Gene Therapies ...
